arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Solventum Corporation

SOLV Health Care Medical/Dental Instruments
$91.69
▼ -0.1% Today
as of Sep 4, 16:54 ET
Last 30 days +6.41% Jul 28 → Sep 04
$82.20 $84.95 $87.70 $90.45 $93.20 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$91.40
High
$92.28
Low
$91.38
Volume
$576,348
Avg Vol
$1M
Mkt Cap
$14.7B
P/E (TTM)
11.73
Beta
—
52w High
$94.16
52w Low
$62.38
Div Yield
—
Shares Out
$170M

Recent Press Releases & News last 60 days · 25 items

Sep 4 · 15:30 Zacks
Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?
Sep 2 · 20:05 PR PR Newswire
Solventum to Participate in the 2026 Wells Fargo Healthcare Conference
Sep 2 · 17:54 Zacks
Should Investors Buy SOLV as Growth Improves but Debt Risks Persist?
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$62
$94
92% of range
Avg surprise (last 3)
+12.9%
Avg reaction (last 2)
+2.1%
100% positive
Latest IV / EM
31%
EM ±4.8% · $90 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.51$2.19$3.87$5.54$7.22 Actual $1.70Actual $1.86Actual $2.66Actual $1.37Actual $0.51Actual $0.70Actual $1.34Est $1.19Actual $1.69Est $1.45Actual $7.22Actual $1.48Est $1.35Actual $0.53 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$0$580M$1.2B$1.7B$2.3B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.53 — — — — financials
Tue May 5, 2026Mar/2026 $1.48 $1.35 +9.6% +10.4% +2.4% earnings
Tue Sep 30, 2025Sep 2025 $7.22 — — — — financials
Thu Aug 7, 2025Jun/2025 $1.69 $1.45 +16.6% — — earnings
Thu May 8, 2025Mar/2025 $1.34 $1.19 +12.6% — +1.7% earnings
Mon Sep 30, 2024Sep 2024 $0.70 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.51 — — — — financials
Sun Mar 31, 2024Mar 2024 $1.37 — — — — financials
Sat Sep 30, 2023Sep 2023 $2.66 — — — — financials
Fri Jun 30, 2023Jun 2023 $1.86 — — — — financials
Fri Mar 31, 2023Mar 2023 $1.70 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$2.21B$2.01B—$2.10B$2.16B$2.07B—$2.08B
Cost of revenue————————
Gross profit$1.29B$1.10B—$1.14B$1.18B$1.11B—$1.17B
Operating income$181M$81M—$1.69B$214M$152M—$275M
Net income$92M$13M—$1.27B$90M$137M—$122M
EPS (diluted)$0.53$0.07—$7.22$0.51$0.78—$0.70

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$403M$561M$878M$1.64B$492M$534M$762M$772M
Inventory$1.04B$1.09B$1.07B$1.05B$962M$866M$965M$953M
Total current assets$3.74B$3.58B$3.86B$4.41B$3.21B$3.05B$3.25B$3.35B
Total assets$14.24B$14.10B$14.29B$13.97B$15.07B$14.53B$14.46B$14.74B
Long-term debt$4.57B$4.58B$5.04B$5.14B$7.82B$7.81B$7.81B$7.81B
Total liabilities$9.44B$9.13B$9.24B$8.99B$11.43B$11.27B$11.50B$11.55B
Total equity$4.80B$4.97B$5.05B$4.99B$3.65B$3.26B$2.96B$3.19B

Implied volatility — last 90 days

23%46%68%91%113% Jun 07 — IV 34% · EM ±4.7%Jun 08 — IV 31% · EM ±4.1%Jun 09 — IV 38% · EM ±4.7%Jun 10 — IV 33% · EM ±3.9%Jun 11 — IV 32% · EM ±3.5%Jun 12 — IV 33% · EM ±3.4%Jun 15 — IV 52% · EM ±3.7%Jun 16 — IV 69% · EM ±4.0%Jun 17 — IV 93% · EM ±3.9%Jun 19 — IV 28% · EM ±6.1%Jun 22 — IV 26% · EM ±5.4%Jun 23 — IV 24% · EM ±4.8%Jun 24 — IV 30% · EM ±6.0%Jun 25 — IV 31% · EM ±6.2%Jun 26 — IV 27% · EM ±5.2%Jun 29 — IV 32% · EM ±5.6%Jun 30 — IV 32% · EM ±5.4%Jul 01 — IV 33% · EM ±5.5%Jul 02 — IV 30% · EM ±4.9%Jul 03 — IV 31% · EM ±4.9%Jul 06 — IV 28% · EM ±3.9%Jul 07 — IV 33% · EM ±4.4%Jul 08 — IV 41% · EM ±5.1%Jul 09 — IV 33% · EM ±3.9%Jul 10 — IV 40% · EM ±4.4%Jul 13 — IV 52% · EM ±4.3%Jul 14 — IV 43% · EM ±3.1%Jul 15 — IV 55% · EM ±3.2%Jul 16 — IV 91% · EM ±3.8%Jul 20 — IV 36% · EM ±8.4%Jul 21 — IV 41% · EM ±9.5%Jul 22 — IV 39% · EM ±8.9%Jul 23 — IV 40% · EM ±9.0%Jul 24 — IV 41% · EM ±9.0%Jul 27 — IV 37% · EM ±7.8%Jul 28 — IV 41% · EM ±8.4%Jul 29 — IV 43% · EM ±8.5%Jul 30 — IV 43% · EM ±8.5%Jul 31 — IV 40% · EM ±7.6%Aug 03 — IV 44% · EM ±7.8%Aug 04 — IV 47% · EM ±8.0%Aug 05 — IV 45% · EM ±7.5%Aug 06 — IV 34% · EM ±5.6%Aug 07 — IV 34% · EM ±5.3%Aug 10 — IV 33% · EM ±4.6%Aug 11 — IV 35% · EM ±4.6%Aug 12 — IV 29% · EM ±3.7%Aug 13 — IV 27% · EM ±3.2%Aug 14 — IV 28% · EM ±3.1%Aug 17 — IV 42% · EM ±3.5%Aug 18 — IV 49% · EM ±3.5%Aug 19 — IV 53% · EM ±3.1%Aug 20 — IV 113% · EM ±4.7%Aug 24 — IV 35% · EM ±7.3%Aug 25 — IV 32% · EM ±6.5%Aug 26 — IV 31% · EM ±6.2%Aug 27 — IV 35% · EM ±6.8%Aug 28 — IV 29% · EM ±5.5%Aug 31 — IV 34% · EM ±6.0%Sep 01 — IV 36% · EM ±6.2%Sep 02 — IV 32% · EM ±5.4%Sep 03 — IV 33% · EM ±5.3%Sep 04 — IV 31% · EM ±4.8%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in